$PCRX
Pacira Biosciences Inc Stock $pcrx

$pcrx Overview Financials Valuation SEC Filings Company Website

2021 Q2 Form 10-Q Financial Statement

#000139681421000050 Filed on August 03, 2021

Income Statement

Concept	2021 Q2	2020 Q2	2020 Q1
Revenue	$135.6M	$75.51M	$105.7M
YoY Change	79.58%	-26.41%	15.74%
Cost Of Revenue	$35.25M	$22.31M	$29.73M
YoY Change	58.03%	-11.49%	8.9%
Gross Profit	$100.3M	$53.20M	$75.95M
YoY Change	88.61%	-31.27%	18.66%
Gross Profit Margin	74.0%	70.46%	71.87%
Selling, General & Admin	$50.81M	$43.34M	$44.78M
YoY Change	17.24%	-11.77%	-5.34%
% of Gross Profit	50.64%	81.47%	58.96%
Research & Development	$12.57M	$13.62M	$15.82M
YoY Change	-7.69%	-23.6%	9.98%
% of Gross Profit	12.53%	25.6%	20.83%
Depreciation & Amortization	$2.900M	$3.000M	$4.821M
YoY Change	-3.33%	-14.29%	33.92%
% of Gross Profit	2.89%	5.64%	6.35%
Operating Expenses	$63.39M	$56.96M	$60.60M
YoY Change	11.28%	-41.47%	-32.84%
Operating Profit	$34.84M	-$7.147M	$17.09M
YoY Change	-587.52%	-235.49%	1484.24%
Interest Expense	$7.023M	$5.456M	$6.022M
YoY Change	28.72%	-7.18%	3.58%
% of Operating Profit	20.16%		35.23%
Other Income/Expense, Net	-$9.195M	-$164.0K	-$8.537M
YoY Change	5506.71%	-96.05%	137.34%
Pretax Income	$25.65M	-$7.311M	$8.557M
YoY Change	-450.81%	-748.71%	-439.83%
Income Tax	$6.567M	-$42.00K	$400.0K
% Of Pretax Income	25.6%		4.67%
Net Earnings	$19.08M	-$7.269M	$8.159M
YoY Change	-362.5%	-366.26%	-394.44%
Net Earnings / Revenue	14.07%	-9.63%	7.72%
Basic Earnings Per Share	$0.43	-$0.17	$0.19
Diluted Earnings Per Share	$0.42	-$0.17	$0.19
COMMON SHARES
Basic Shares Outstanding	44.15M shares	42.22M shares	42.03M shares
Diluted Shares Outstanding	45.59M shares	42.22M shares	42.79M shares

Balance Sheet

Concept	2021 Q2	2020 Q2	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$646.6M	$326.8M	$318.5M
YoY Change	97.86%	11.84%	-22.77%
Cash & Equivalents	$105.8M	$78.55M	$54.59M
Short-Term Investments	$540.8M	$248.2M	$263.9M
Other Short-Term Assets	$12.36M	$18.30M	$14.50M
YoY Change	-32.44%	115.29%	54.26%
Inventory	$65.26M	$66.69M	$59.67M
Prepaid Expenses
Receivables	$68.36M	$44.01M	$38.99M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$792.6M	$455.8M	$431.6M
YoY Change	73.88%	15.51%	-15.15%
LONG-TERM ASSETS
Property, Plant & Equipment	$153.3M	$113.3M	$108.1M
YoY Change	35.31%	7.4%	0.98%
Goodwill	$99.50M	$99.50M	$99.50M
YoY Change	0.0%	-1.03%	60.48%
Intangibles	$92.59M	$100.5M	$102.4M
YoY Change	-7.83%	-7.26%
Long-Term Investments	$17.97M	$10.00M	$42.10M
YoY Change	79.66%	-76.42%	198.58%
Other Assets	$98.60M
YoY Change
Total Long-Term Assets	$533.3M	$410.3M	$389.8M
YoY Change	29.97%	4.34%	85.19%
TOTAL ASSETS
Total Short-Term Assets	$792.6M	$455.8M	$431.6M
Total Long-Term Assets	$533.3M	$410.3M	$389.8M
Total Assets	$1.326B	$866.1M	$821.4M
YoY Change	53.08%	9.93%	14.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$12.18M	$9.160M	$15.85M
YoY Change	32.96%	-31.37%	18.56%
Accrued Expenses	$52.16M	$47.68M	$44.72M
YoY Change	9.39%	-8.14%	12.65%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$153.7M
YoY Change
Total Short-Term Liabilities	$228.7M	$70.58M	$80.31M
YoY Change	224.01%	-14.96%	36.14%
LONG-TERM LIABILITIES
Long-Term Debt	$321.7M	$314.2M	$310.1M
YoY Change	2.39%	5.37%	5.33%
Other Long-Term Liabilities	$7.697M	$2.984M	$1.535M
YoY Change	157.94%	-66.82%	-82.93%
Total Long-Term Liabilities	$7.697M	$2.984M	$1.535M
YoY Change	157.94%	-66.82%	-82.93%
TOTAL LIABILITIES
Total Short-Term Liabilities	$228.7M	$70.58M	$80.31M
Total Long-Term Liabilities	$7.697M	$2.984M	$1.535M
Total Liabilities	$638.7M	$478.0M	$447.3M
YoY Change	33.62%	7.12%	14.22%
SHAREHOLDERS EQUITY
Retained Earnings	-$224.4M	-$398.5M	-$391.2M
YoY Change	-43.68%	2.6%	0.02%
Common Stock	$44.00K	$43.00K	$42.00K
YoY Change	2.33%	2.38%	2.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$687.2M	$388.1M	$374.0M
YoY Change
Total Liabilities & Shareholders Equity	$1.326B	$866.1M	$821.4M
YoY Change	53.08%	9.93%	14.21%

Cashflow Statement

Concept	2021 Q2	2020 Q2	2020 Q1
OPERATING ACTIVITIES
Net Income	$19.08M	-$7.269M	$8.159M
YoY Change	-362.5%	-366.26%	-394.44%
Depreciation, Depletion And Amortization	$2.900M	$3.000M	$4.821M
YoY Change	-3.33%	-14.29%	33.92%
Cash From Operating Activities	$30.14M	-$15.63M	$6.208M
YoY Change	-292.8%	-168.67%	77.42%
INVESTING ACTIVITIES
Capital Expenditures	-$10.55M	-$8.910M	$6.724M
YoY Change	18.45%	334.63%	233.2%
Acquisitions
YoY Change
Other Investing Activities	$13.58M	$45.03M	-$21.84M
YoY Change	-69.84%	-125.05%	-127.13%
Cash From Investing Activities	$3.029M	$36.13M	-$28.57M
YoY Change	-91.62%	-119.87%	-136.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	5.903M	3.460M	-$1.281M
YoY Change	70.61%	-7.49%	-341.7%
NET CHANGE
Cash From Operating Activities	30.14M	-15.63M	$6.208M
Cash From Investing Activities	3.029M	36.13M	-$28.57M
Cash From Financing Activities	5.903M	3.460M	-$1.281M
Net Change In Cash	39.07M	23.96M	-$23.64M
YoY Change	63.05%	-115.43%	-128.65%
FREE CASH FLOW
Cash From Operating Activities	$30.14M	-$15.63M	$6.208M
Capital Expenditures	-$10.55M	-$8.910M	$6.724M
Free Cash Flow	$40.69M	-$6.720M	-$516.0K
YoY Change	-705.49%	-127.09%	-134.84%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001396814
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2021-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-35060
	dei	Entity Registrant Name EntityRegistrantName	PACIRA BIOSCIENCES, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	51-0619477
	dei	Entity Address Address Line1 EntityAddressAddressLine1	5 Sylvan Way, Suite 300
	dei	Entity Address City Or Town EntityAddressCityOrTown	Parsippany
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07054
	dei	City Area Code CityAreaCode	973
	dei	Local Phone Number LocalPhoneNumber	254-3560
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	PCRX
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	44454792	shares
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	105774000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	99957000	USD
CY2021Q2	us-gaap	Short Term Investments ShortTermInvestments	540821000	USD
CY2020Q4	us-gaap	Short Term Investments ShortTermInvestments	421705000	USD
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	68357000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	53046000	USD
CY2021Q2	us-gaap	Inventory Net InventoryNet	65264000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	64650000	USD
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	12363000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	12265000	USD
CY2021Q2	us-gaap	Assets Current AssetsCurrent	792579000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	651623000	USD
CY2021Q2	us-gaap	Long Term Investments LongTermInvestments	0	USD
CY2020Q4	us-gaap	Long Term Investments LongTermInvestments	95459000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	153302000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	136688000	USD
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	71252000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	74492000	USD
CY2021Q2	us-gaap	Goodwill Goodwill	99547000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	99547000	USD
CY2021Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	92588000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	96521000	USD
CY2021Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	98599000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	106164000	USD
CY2021Q2	pcrx	Equity Method Investments And Other Assets EquityMethodInvestmentsAndOtherAssets	17966000	USD
CY2020Q4	pcrx	Equity Method Investments And Other Assets EquityMethodInvestmentsAndOtherAssets	14019000	USD
CY2021Q2	us-gaap	Assets Assets	1325833000	USD
CY2020Q4	us-gaap	Assets Assets	1274513000	USD
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	12179000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	10431000	USD
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	52163000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	70974000	USD
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5644000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7425000	USD
CY2021Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	153681000	USD
CY2021Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	153681000	USD
CY2020Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	149648000	USD
CY2020Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	149648000	USD
CY2021Q2	pcrx	Contingent Consideration Current ContingentConsiderationCurrent	5026000	USD
CY2020Q4	pcrx	Contingent Consideration Current ContingentConsiderationCurrent	14736000	USD
CY2021Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	0	USD
CY2020Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	114000	USD
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	228693000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	253328000	USD
CY2021Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	321708000	USD
CY2021Q2	us-gaap	Costs And Expenses CostsAndExpenses	100747000	USD
CY2020Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	313030000	USD
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	68235000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	71025000	USD
CY2021Q2	pcrx	Contingent Consideration Noncurrent ContingentConsiderationNoncurrent	12332000	USD
CY2020Q4	pcrx	Contingent Consideration Noncurrent ContingentConsiderationNoncurrent	13610000	USD
CY2021Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7697000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3832000	USD
CY2021Q2	us-gaap	Liabilities Liabilities	638665000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	654825000	USD
CY2021Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	44436630	shares
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	44436630	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43636929	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43636929	shares
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	44000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	44000	USD
CY2021Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	911368000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	873201000	USD
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-224425000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-253875000	USD
CY2021Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	181000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	318000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	687168000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	619688000	USD
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1325833000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1274513000	USD
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	135590000	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	75505000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	254617000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	181189000	USD
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	35248000	USD
CY2020Q2	us-gaap	Cost Of Revenue CostOfRevenue	22305000	USD
	pcrx	Acquisition Related Gain Loss Product Discontinuation Costs And Other Net AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet	2290000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	66597000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	52037000	USD
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12573000	USD
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13620000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	28453000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	29440000	USD
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	50813000	USD
CY2020Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	43342000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	99335000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	88122000	USD
CY2021Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1967000	USD
CY2020Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1967000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3933000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3933000	USD
CY2021Q2	pcrx	Acquisition Related Gain Loss Product Discontinuation Costs And Other Net AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet	-146000	USD
CY2020Q2	pcrx	Acquisition Related Gain Loss Product Discontinuation Costs And Other Net AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet	-1418000	USD
	pcrx	Acquisition Related Gain Loss Product Discontinuation Costs And Other Net AcquisitionRelatedGainLossProductDiscontinuationCostsAndOtherNet	-2019000	USD
CY2020Q2	us-gaap	Costs And Expenses CostsAndExpenses	82652000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	200337000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	171242000	USD
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	34843000	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-7147000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	54280000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	9947000	USD
CY2021Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	224000	USD
CY2020Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	1323000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	639000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	2911000	USD
CY2021Q2	us-gaap	Interest Expense InterestExpense	7023000	USD
CY2020Q2	us-gaap	Interest Expense InterestExpense	5456000	USD
	us-gaap	Interest Expense InterestExpense	13994000	USD
	us-gaap	Interest Expense InterestExpense	11477000	USD
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2396000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-136000	USD
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9195000	USD
CY2020Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-164000	USD
CY2020Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3969000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2554000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-15909000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-8702000	USD
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	25648000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7311000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	38371000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1245000	USD
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6567000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-42000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8921000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	356000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	19081000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-7269000	USD
	us-gaap	Net Income Loss NetIncomeLoss	29450000	USD
	us-gaap	Net Income Loss NetIncomeLoss	889000	USD
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.43
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.67
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.42
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.64
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44145000	shares
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42221000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43989000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42126000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45592000	shares
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42221000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45779000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42861000	shares
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	19081000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-7269000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	16022000	USD
	us-gaap	Net Income Loss NetIncomeLoss	29450000	USD
	us-gaap	Net Income Loss NetIncomeLoss	889000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	12000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	2536000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-138000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1168000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-3000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	0	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	1000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	0	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	9000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2536000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-137000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1168000	USD
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	19090000	USD
CY2020Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4733000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	29313000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2057000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	650818000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5225000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1574000	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10461000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	9000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	19081000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	687168000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	374036000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	8202000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1421000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9222000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2536000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-7269000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	388148000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	619688000	USD
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1574000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	20571000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-137000	USD
	us-gaap	Net Income Loss NetIncomeLoss	29450000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	687168000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	354944000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	11656000	USD
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1421000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	18070000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1168000	USD
	us-gaap	Net Income Loss NetIncomeLoss	889000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	388148000	USD
	us-gaap	Net Income Loss NetIncomeLoss	29450000	USD
	us-gaap	Net Income Loss NetIncomeLoss	889000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	7613000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9748000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9810000	USD
	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	1310000	USD
	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	883000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	11401000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	7254000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	10000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-22000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	20571000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	18070000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-988000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-2312000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	2601000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-8000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	15312000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3517000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	615000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	8394000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	944000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1701000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2156000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3517000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-18140000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-21468000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-964000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-3052000	USD
	us-gaap	Payment For Contingent Consideration Liability Operating Activities PaymentForContingentConsiderationLiabilityOperatingActivities	5662000	USD
	us-gaap	Payment For Contingent Consideration Liability Operating Activities PaymentForContingentConsiderationLiabilityOperatingActivities	9409000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	42215000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9416000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	23624000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15630000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	318132000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	72263000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	294288000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	95450000	USD
	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	14220000	USD
	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	0	USD
	us-gaap	Proceeds From Sale Of Longterm Investments ProceedsFromSaleOfLongtermInvestments	9057000	USD
	us-gaap	Proceeds From Sale Of Longterm Investments ProceedsFromSaleOfLongtermInvestments	0	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-52631000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	7557000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	15997000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6353000	USD
	pcrx	Proceedsfrom Shares Issued Under Employee Stock Purchase Plans ProceedsfromSharesIssuedUnderEmployeeStockPurchasePlans	1574000	USD
	pcrx	Proceedsfrom Shares Issued Under Employee Stock Purchase Plans ProceedsfromSharesIssuedUnderEmployeeStockPurchasePlans	1421000	USD
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	1338000	USD
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	5591000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	16233000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2183000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5817000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	324000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99957000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	78228000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	105774000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	78552000	USD
	us-gaap	Interest Paid Net InterestPaidNet	3586000	USD
	us-gaap	Interest Paid Net InterestPaidNet	4097000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1447000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	80000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	8096000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1903000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2021Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	34324000	USD
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	26886000	USD
CY2021Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	14400000	USD
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	16266000	USD
CY2021Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	16540000	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	21498000	USD
CY2021Q2	us-gaap	Inventory Net InventoryNet	65264000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	64650000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	237348000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	215048000	USD
CY2021Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	84046000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	78360000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	153302000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	136688000	USD
CY2021Q2	us-gaap	Depreciation Depreciation	2900000	USD
CY2020Q2	us-gaap	Depreciation Depreciation	3000000.0	USD
	us-gaap	Depreciation Depreciation	5800000	USD
	us-gaap	Depreciation Depreciation	5900000	USD
CY2021Q2	pcrx	Foreign Property Plantand Equipment Net ForeignPropertyPlantandEquipmentNet	68600000	USD
CY2020Q4	pcrx	Foreign Property Plantand Equipment Net ForeignPropertyPlantandEquipmentNet	67500000	USD
CY2020Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	2000000.0	USD
CY2021Q2	us-gaap	Asset Retirement Obligation AssetRetirementObligation	2000000.0	USD
CY2021Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P9Y2M12D
CY2021Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	2922000	USD
CY2020Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	2422000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	5843000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	3986000	USD
CY2021Q2	us-gaap	Variable Lease Cost VariableLeaseCost	424000	USD
CY2020Q2	us-gaap	Variable Lease Cost VariableLeaseCost	601000	USD
	us-gaap	Variable Lease Cost VariableLeaseCost	902000	USD
	us-gaap	Variable Lease Cost VariableLeaseCost	1049000	USD
CY2021Q2	us-gaap	Lease Cost LeaseCost	3346000	USD
CY2020Q2	us-gaap	Lease Cost LeaseCost	3023000	USD
	us-gaap	Lease Cost LeaseCost	6745000	USD
	us-gaap	Lease Cost LeaseCost	5035000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	7177000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	8503000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	42101000	USD
CY2021Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y8M15D
CY2020Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y6M18D
CY2021Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0689
CY2020Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0688
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	5350000	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	10423000	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	10697000	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	10980000	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	11271000	USD
CY2021Q2	pcrx	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	50802000	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	99523000	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	25644000	USD
CY2021Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	73879000	USD
	pcrx	Lessee Operating Lease Lease Not Yet Commenced Number Of Contracts LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts	1	contract
CY2021Q2	pcrx	Lessee Operating Lease Lease Not Yet Commenced Liability Remainder Of Fiscal Year LesseeOperatingLeaseLeaseNotYetCommencedLiabilityRemainderOfFiscalYear	0	USD
CY2021Q2	pcrx	Lessee Operating Lease Lease Not Yet Commenced Liability Due Year One LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearOne	439000	USD
CY2021Q2	pcrx	Lessee Operating Lease Lease Not Yet Commenced Liability Due Year Two LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo	453000	USD
CY2021Q2	pcrx	Lessee Operating Lease Lease Not Yet Commenced Liability Due Year Three LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree	466000	USD
CY2021Q2	pcrx	Lessee Operating Lease Lease Not Yet Commenced Liability Due Year Four LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour	480000	USD
CY2021Q2	pcrx	Lessee Operating Lease Lease Not Yet Commenced Liability Due After Year Four LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueAfterYearFour	495000	USD
CY2021Q2	pcrx	Lessee Operating Lease Lease Not Yet Commenced Liability LesseeOperatingLeaseLeaseNotYetCommencedLiability	2333000	USD
CY2021Q2	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	USD
	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	USD
CY2021Q2	us-gaap	Goodwill Goodwill	99500000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	99500000	USD
CY2021Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2000000.0	USD
CY2020Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2000000.0	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3900000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3900000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	3900000	USD
CY2021Q2	pcrx	Finite Lived Intangible Assets Amortization Expense Annual Amount Period1 FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1	7900000	USD
CY2021Q2	pcrx	Finite Lived Intangible Assets Amortization Expense Annual Amount Period2 FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2	2200000	USD
	pcrx	Settlement Period Convertible Debt Conversion Request SettlementPeriodConvertibleDebtConversionRequest	P40D
	pcrx	Deferred Tax Expense Associated To The Equity Component Of Convertible Debt DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt	20500000	USD
	pcrx	Amortization Period Of Transaction Costs Attributable To Liability Component Of Convertible Debt AmortizationPeriodOfTransactionCostsAttributableToLiabilityComponentOfConvertibleDebt	P5Y
	pcrx	Transaction Costs Attributable To The Equity Component Of Convertible Debt TransactionCostsAttributableToTheEquityComponentOfConvertibleDebt	2700000	USD
CY2021Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	1713000	USD
CY2020Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	2048000	USD
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	3418000	USD
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	4097000	USD
CY2021Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	659000	USD
CY2020Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	444000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1310000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	883000	USD
CY2021Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	5744000	USD
CY2020Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3660000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	11401000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	7254000	USD
CY2021Q2	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	1093000	USD
CY2020Q2	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	696000	USD
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	2135000	USD
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	757000	USD
CY2021Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	7023000	USD
CY2020Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	5456000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	13994000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	11477000	USD
CY2021Q2	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0670
	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	13048000	USD
CY2020Q2	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0781
	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0670
	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0781
CY2021Q2	us-gaap	Share Price SharePrice	60.68
	pcrx	Milestone Payment MilestonePayment	7000000.0	USD
CY2021Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	540688000	USD
CY2021Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	137000	USD
CY2021Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	4000	USD
CY2021Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	540821000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	516845000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	350000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	31000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	517164000	USD
CY2021Q2	us-gaap	Interest Receivable InterestReceivable	900000	USD
CY2020Q4	us-gaap	Interest Receivable InterestReceivable	1600000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	1500000	shares
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10461000	USD
CY2020Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9222000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	20571000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18070000	USD
CY2021Q2	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	6552000	USD
CY2020Q2	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	6388000	USD
	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	12614000	USD
CY2021Q2	us-gaap	Restricted Stock Expense RestrictedStockExpense	3646000	USD
CY2020Q2	us-gaap	Restricted Stock Expense RestrictedStockExpense	2636000	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	7038000	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	5037000	USD
CY2021Q2	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	263000	USD
CY2020Q2	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	198000	USD
	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	485000	USD
	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	419000	USD
CY2021Q2	us-gaap	Share Based Compensation ShareBasedCompensation	10461000	USD
CY2020Q2	us-gaap	Share Based Compensation ShareBasedCompensation	9222000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	20571000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	18070000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6235118	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	45.98
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	692352	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	61.42
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	479367	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	33.42
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	194183	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	45.59
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	22116	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	76.75
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6231804	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	48.56
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	27.49
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.85
	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	31230	shares
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-49000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	0	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	19081000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-7269000	USD
	us-gaap	Net Income Loss NetIncomeLoss	29450000	USD
	us-gaap	Net Income Loss NetIncomeLoss	889000	USD
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44145000	shares
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42221000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43989000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42126000	shares
CY2021Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2020Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	76000	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45592000	shares
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42221000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45779000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42861000	shares
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.43
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.67
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.42
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.64
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2021Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2114000	shares
CY2020Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7522000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1503000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5533000	shares
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	25863000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-6645000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	41795000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	6400000	USD
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-215000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-666000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-3424000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-5155000	USD
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	25648000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7311000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	38371000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1245000	USD
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6600000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8900000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	400000	USD

Files In Submission

Name	View Source	Status
0001396814-21-000050-index-headers.html	Edgar Link	pending
0001396814-21-000050-index.html	Edgar Link	pending
0001396814-21-000050.txt	Edgar Link	pending
0001396814-21-000050-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pcrx-20210630.htm	Edgar Link	pending
pcrx-20210630.xsd	Edgar Link	pending
pcrx-20210630_cal.xml	Edgar Link	unprocessable
pcrx-20210630_def.xml	Edgar Link	unprocessable
pcrx-20210630_g1.jpg	Edgar Link	pending
pcrx-20210630_g2.jpg	Edgar Link	pending
pcrx-20210630_htm.xml	Edgar Link	completed
pcrx-20210630_lab.xml	Edgar Link	unprocessable
pcrx-20210630_pre.xml	Edgar Link	unprocessable
pcrx-6302021xex311.htm	Edgar Link	pending
pcrx-6302021xex312.htm	Edgar Link	pending
pcrx-6302021xex321.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PCRX
Pacira Biosciences Inc Stock $pcrx

2021 Q2 Form 10-Q Financial Statement

#000139681421000050 Filed on August 03, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX Pacira Biosciences Inc Stock $pcrx

2021 Q2 Form 10-Q Financial Statement

#000139681421000050 Filed on August 03, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX
Pacira Biosciences Inc Stock $pcrx